Career history of Kevin D. Cooksy
Former positions of Kevin D. Cooksy
| Companies | Position | Start | End |
|---|---|---|---|
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Corporate Officer/Principal | 2009-07-01 | 2009-12-31 |
| THERMOGENESIS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2011-07-31 | - |
| General Counsel | 2012-02-20 | - | |
| Corporate Officer/Principal | 2011-07-31 | 2012-02-20 | |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - | - |
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - | - |
| Gerent LLC | Corporate Officer/Principal | 2000-12-31 | - |
| REFLECT SCIENTIFIC, INC. | Corporate Officer/Principal | 2011-07-08 | - |
| Corporate Secretary | 2004-12-31 | 2011-07-08 | |
| Treasurer | 2004-12-31 | 2011-07-08 |
Training of Kevin D. Cooksy
| Lake Forest College | Masters Business Admin |
| Northern Illinois University | Undergraduate Degree |
| Mcgeorge School of Law | Graduate Degree |
Statistics
International
| United States | 9 |
| 2 |
Operational
| Corporate Officer/Principal | 6 |
| Corporate Secretary | 1 |
| Treasurer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| THERMOGENESIS HOLDINGS, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| AGILENT TECHNOLOGIES, INC. | Commercial Services |
| REFLECT SCIENTIFIC, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
| Gerent LLC |
- Stock Market
- Insiders
- Kevin D. Cooksy
- Experience
